Insulin degludec and liraglutide Subcutaneous and Utibron Neohaler
Determining the interaction of Insulin degludec and liraglutide Subcutaneous and Utibron Neohaler and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
Generic Name: glycopyrrolate / indacaterol
Brand name: Utibron Neohaler
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec and liraglutide Subcutaneous-Uticap
- Insulin degludec and liraglutide Subcutaneous-Utira-C
- Insulin degludec and liraglutide Subcutaneous-Utira-C Tablets
- Insulin degludec and liraglutide Subcutaneous-Utrona-C
- Insulin degludec and liraglutide Subcutaneous-Uvadex
- Insulin degludec and liraglutide Subcutaneous-Uvadex injection
- Utibron Neohaler-Insulin degludec Subcutaneous
- Utibron Neohaler-Insulin detemir
- Utibron Neohaler-Insulin Detemir (Cartridges and Prefilled Syringes)
- Utibron Neohaler-Insulin Detemir (Vials)
- Utibron Neohaler-Insulin detemir Subcutaneous
- Utibron Neohaler-Insulin glargine